Last reviewed · How we verify

Staphylococcus and Neisseria Tablets

Peking University Third Hospital · FDA-approved active Small molecule

Staphylococcus and Neisseria Tablets is a bacterial vaccine Small molecule drug developed by Peking University Third Hospital. It is currently FDA-approved for Prevention of Staphylococcus infections, Prevention of Neisseria infections. Also known as: H37023540.

This is a vaccine formulation containing antigens from Staphylococcus and Neisseria bacteria designed to stimulate immune responses against these pathogens.

This is a vaccine formulation containing antigens from Staphylococcus and Neisseria bacteria designed to stimulate immune responses against these pathogens. Used for Prevention of Staphylococcus infections, Prevention of Neisseria infections.

At a glance

Generic nameStaphylococcus and Neisseria Tablets
Also known asH37023540
SponsorPeking University Third Hospital
Drug classbacterial vaccine
ModalitySmall molecule
Therapeutic areaImmunology / Infectious Disease
PhaseFDA-approved

Mechanism of action

The tablet formulation presents bacterial antigens from Staphylococcus and Neisseria species to the immune system, triggering both humoral and cellular immune responses. This approach aims to provide protective immunity against infections caused by these gram-positive and gram-negative bacteria respectively. The exact antigenic composition and delivery mechanism are not publicly detailed.

Approved indications

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Staphylococcus and Neisseria Tablets

What is Staphylococcus and Neisseria Tablets?

Staphylococcus and Neisseria Tablets is a bacterial vaccine drug developed by Peking University Third Hospital, indicated for Prevention of Staphylococcus infections, Prevention of Neisseria infections.

How does Staphylococcus and Neisseria Tablets work?

This is a vaccine formulation containing antigens from Staphylococcus and Neisseria bacteria designed to stimulate immune responses against these pathogens.

What is Staphylococcus and Neisseria Tablets used for?

Staphylococcus and Neisseria Tablets is indicated for Prevention of Staphylococcus infections, Prevention of Neisseria infections.

Who makes Staphylococcus and Neisseria Tablets?

Staphylococcus and Neisseria Tablets is developed and marketed by Peking University Third Hospital (see full Peking University Third Hospital pipeline at /company/peking-university-third-hospital).

Is Staphylococcus and Neisseria Tablets also known as anything else?

Staphylococcus and Neisseria Tablets is also known as H37023540.

What drug class is Staphylococcus and Neisseria Tablets in?

Staphylococcus and Neisseria Tablets belongs to the bacterial vaccine class. See all bacterial vaccine drugs at /class/bacterial-vaccine.

What development phase is Staphylococcus and Neisseria Tablets in?

Staphylococcus and Neisseria Tablets is FDA-approved (marketed).

Related